Association between symptoms and objective physiological outcomes in severe COVID-19 pneumonia survivors

P. Zamani (London, United Kingdom), S. Mehrotra (London, United Kingdom), R. D'Cruz (London, United Kingdom), S. Mathew (London, United Kingdom), A. Byrne (London, United Kingdom), M. Choudhury (London, United Kingdom), T. Fleming (London, United Kingdom), S. Norton (London, United Kingdom), S. Birring (London, United Kingdom), A. Patel (London, United Kingdom), I. Patel (London, United Kingdom), F. Perrin (London, United Kingdom), M. Waller (London, United Kingdom), C. Jolley (London, United Kingdom)

Source: Virtual Congress 2021 – Respiratory function after COVID-19 and mechanical ventilation
Session: Respiratory function after COVID-19 and mechanical ventilation
Session type: Oral Presentation
Number: 4051

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Zamani (London, United Kingdom), S. Mehrotra (London, United Kingdom), R. D'Cruz (London, United Kingdom), S. Mathew (London, United Kingdom), A. Byrne (London, United Kingdom), M. Choudhury (London, United Kingdom), T. Fleming (London, United Kingdom), S. Norton (London, United Kingdom), S. Birring (London, United Kingdom), A. Patel (London, United Kingdom), I. Patel (London, United Kingdom), F. Perrin (London, United Kingdom), M. Waller (London, United Kingdom), C. Jolley (London, United Kingdom). Association between symptoms and objective physiological outcomes in severe COVID-19 pneumonia survivors. 4051

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical signs and symptoms as predictors of pneumonia in hospitalized children
Source: Annual Congress 2008 - Miscellaneous respiratory infections
Year: 2008

Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study
Source: Eur Respir J, 58 (6) 2004474; 10.1183/13993003.04474-2020
Year: 2021



Clinical characteristics and burden of illness in a cohort of severe asthma patients
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016


The impact of depression in recovery and outcome of patients hospitalized for COPD exacerbation
Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care
Year: 2011

Associations between clinical, laboratory and therapeutical parameters on admission and adverse outcomes in patients hospitalized for COPD exacerbations
Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Year: 2010


Study of clinical presentation and predictors of adverse outcome in patients admitted for acute exacerbation of COPD.
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019

Physiological impairments and exacerbation risk in COPD patients with less symptom and no frequent exacerbation history.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021


Clinical features associated with mortality in patients with community acquired pneumonia requiring hospitalisation
Source: Eur Respir J 2004; 24: Suppl. 48, 414s
Year: 2004

Comparison of severity scores to predict outcomes in elderly patients with community acquired pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015


Clinical characteristics and outcome of patients with acute hypercapnic respiratory failure from a developing country
Source: Eur Respir J 2004; 24: Suppl. 48, 542s
Year: 2004

Clinical characteristics and outcomes in hospitalized COVID-19 patients with COPD
Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Year: 2021


Influence of statin therapy on clinical symptoms, severity and prognosis in patients with community acquired pneumonia
Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia
Year: 2008

Clinical characteristics and outcomes of hospitalized COVID-19 pneumonia : impact of gender
Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19
Year: 2021


Clinical profile and outcomes of patients with moderate and high risk community acquired pneumonia with mixed pathogens
Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication
Year: 2007


Community acquired pneumonia in patients with neuromuscular disorders. Severity assessment and outcome
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008

Evaluation of severity, inflammatory response and adherence to treatment guidelines impact on community-acquired pneumonia outcomes
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


Health status measurement in COPD patients. Correlations with dyspnea and physiologic outcomes
Source: Eur Respir J 2005; 26: Suppl. 49, 515s
Year: 2005

Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015

Short physical performance battery as a predictor of adverse outcomes following hospitalisation for an acute exacerbation of COPD
Source: International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases
Year: 2016

Clinical characteristics and symptoms in older and younger patients with community acquired pneumonia
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008